Search results for " Hearing"
showing 10 items of 301 documents
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment
2022
PURPOSE To evaluate teprotumumab safety/efficacy in patients with thyroid eye disease (TED) who were nonresponsive or who experienced a disease flare. DESIGN The Treatment of Graves' Orbitopathy to Reduce Proptosis with Teprotumumab Infusions in an Open-Label Clinical Extension Study (OPTIC-X) is a teprotumumab treatment and re-treatment trial following the placebo-controlled teprotumumab Phase 3 Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis with Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study (OPTIC) trial. PARTICIPANTS Patients who previously received placebo (n = 37) or teprotumumab (n = 14) in OPTIC. METHODS OPTIC nonresponders or …
Understanding Deafhood: in search of its meanings.
2013
The authors argue that Deafhood (a term coined by Dr. Paddy Ladd) is an open-ended concept with an essentialist core. They describe how deaf people who have attended their Deafhood lectures and workshops have perceived different aspects of the Deafhood concept, and compare the basic tenets of Deafhood and criticisms on Deafhood to theories and criticisms on feminist essentialisms. The authors find that the vagueness and wideness of the Deafhood concept is one of its strengths, though they also find that it is in some respects problematic to combine and unite ontology and liberation theory in one concept. They further suggest that the ontological aspects of Deafhood need to be foregrounded. …
METALANG. Protocolo franco-español de exploración de habilidades metalingüísticas en niños de 6 a 9 años: un estudio preliminar
2012
International audience; In this work are described the principles of functional-pragmatic and the reasons for developing an exploration protocol for natural metalinguistic abilities. This study explains the base hypothesis and structure of METALANG protocol. This protocol consists in a Test and a Questionnaire for parents with two different scales: A = Ability, B = Frequency. Each element of the protocol has 6 sections and 40 items. It is performed a preliminary contrast with 12 subjects aged 6 to 9 years. Among the 12 subjects, 4 were diagnosed with dysphasia. METALANG shows high scores in reliability and internal consistency. This result confirms the hypothesis that it is possible a joint…
Oxidative stress neuroinflammation and cellular stress response in sensorineural hearing loss: novel nutritional therapeutical approaches
2016
This study is intended to validate the hypothesis that changes in the redox state of glutathione, the major endogenous antioxidant, associated with the abnormal expression and activity of cytoprotective vitagenes, which in normal conditions are expressed only at low level may represent a critical factor, involved in the physiopathological changes associated to degenerative damage occurring in cochlear diseases. Moreover modulation of stress responsive vitagenes by nutritional antioxidants can be an effective therapeutic strategy to minimize consequences of oxidative stress associated to the pathogenesis and course of sensorineural hearing loss. One therapeutic approach can be antioxidant su…
Genome-wide association analysis on normal hearing function identifies PCDH20 and SLC28A3 as candidates for hearing function and loss.
2015
Hearing loss and individual differences in normal hearing both have a substantial genetic basis. Although many new genes contributing to deafness have been identified, very little is known about genes/variants modulating the normal range of hearing ability. To fill this gap, we performed a two-stage meta-analysis on hearing thresholds (tested at 0.25, 0.5, 1, 2, 4, 8 kHz) and on pure-tone averages (low-, medium-and high-frequency thresholds grouped) in several isolated populations from Italy and Central Asia (total N = 2636). Here, we detected two genome-wide significant loci close to PCDH20 and SLC28A3 (top hits: rs78043697, P = 4.71E-10 and rs7032430, P = 2.39E-09, respectively). For both…
Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments
2004
The most common mutation in the USH2A gene (Usherin), 2299delG, causes both typical Usher (USH) syndrome type II and atypical USH syndrome, two autosomal recessive disorders, characterised by moderate to severe sensorineural hearing loss and retinitis pigmentosa (RP). Furthermore, the C759F mutation in the USH2A gene has been described in 4.5% of patients with nonsyndromic recessive RP. We have investigated the presence of the 2299delG and/or the C759F mutations in 191 unrelated Spanish patients with different syndromic and nonsyndromic retinal diseases, or with nonsyndromic hearing impairment. The 2299delG mutation was observed in patients with clinical signs of USHII or of atypical USH sy…
Pharmacological treatment of sensorineural hearing loss
2019
Sudden sensorineural hearing loss is a common and alarming symptom of about 360 million people that suffer from hearing impairment worldwide. The sudden sensorineural hearing loss usually arises unilaterally and it is habitually described as greater than 30dB hearing reduction, attributable to lesions of the cochlea, cranial nerve VIII, brainstem and temporal lobe. There are many factor that promote the onset of this lesions such us infections, circulatory diseases, inner ear neoplasia and neurological disorders. This pathology is characterized by primary symptoms such as the impairment of the comprehension of spoken language and the struggling to listen to music. Subsequently, secondary sy…
Das Cogan-I-Syndrom
2003
Wir berichten uber 2 Patienten, die seit dem Sauglings- und Kleinkindesalter unter einem Cogan-I-Syndrom leiden.Bei diesem seltenen Krankheitsbild handelt es sich um eine akute oder schubweise Verschlechterung der Horleistung des Innenohrs mit vestibularer Symptomatik und einer nichtsyphilitischen interstitiellen Keratitis oder anderen entzundlichen okularen Symptomen beim atypischen Cogan-I-Syndrom. Die erste Patientin erkrankte im 5.Lebensjahr an verschiedenen okularen Entzundungen, sodass ein Auge im 8.Lebensjahr erblindete.Zu dieser Zeit begann die Horverschlechterung. Im Alter von 17 Jahren litt die Patientin beidseits unter einer an Taubheit grenzenden Schwerhorigkeit. Bei dem zweiten…
Desempenho ortográfico de escolares do 2º ao 5º ano do ensino público
2011
Submitted by Guilherme Lemeszenski (guilherme@nead.unesp.br) on 2013-08-22T18:45:19Z No. of bitstreams: 1 S2179-64912011000300008.pdf: 281357 bytes, checksum: e4ccc266cc964d955c3f9a17579bdcf6 (MD5) Made available in DSpace on 2013-08-22T18:45:19Z (GMT). No. of bitstreams: 1 S2179-64912011000300008.pdf: 281357 bytes, checksum: e4ccc266cc964d955c3f9a17579bdcf6 (MD5) Previous issue date: 2011-09-01 Made available in DSpace on 2013-09-30T19:34:16Z (GMT). No. of bitstreams: 2 S2179-64912011000300008.pdf: 281357 bytes, checksum: e4ccc266cc964d955c3f9a17579bdcf6 (MD5) S2179-64912011000300008.pdf.txt: 42724 bytes, checksum: 649f10be72958aa8c6dd63eab4ff802e (MD5) Previous issue date: 2011-09-01 Subm…
Audiologic and Subjective Evaluation of Baha ® Attract Device
2017
We included 9 patients implanted with Baha® Attract. All our patients were evaluated by free field tonal audiometry, free field verbal audiometry and free field verbal audiometry with background noise, all the tests were performed with and without the device. To evaluate the subjective component of the implantation, we used the Glasgow Benefit Inventory (GBI) and Abbreviated Profile of Hearing Aid Benefit (APHAB). The auditive assessment with the device showed average auditive thresholds of 35.8dB with improvements of 25.8dB over the previous situation. Speech reception thresholds were 37dB with Baha® Attract, showing improvements of 23dB. Maximum discrimination thresholds showed an average…